Keywords
Last Name
Institution

Bela F. Asztalos

TitleAssistant Professor
InstitutionHuman Nutrition Research Center
DepartmentPublic Health and Community Medicine
AddressUSDA Human Nutrition Research Center
711 Washington Street
Boston MA 02111
Phone(617) 556-3112
Fax(617) 556-3103
vCardDownload vCard

    Collapse Bibliographic 
    Collapse selected publications
    Publications listed below are automatically derived from MEDLINE/PubMed and other sources, which might result in incorrect or missing publications. Faculty can login to make corrections and additions.
    List All   |   Timeline
    1. Asztalos BF, Horvath KV, Mehan M, Yokota Y, Schaefer EJ. Influence of HDL Particles on Cell-Cholesterol Efflux under Various Pathological Conditions. J Lipid Res. 2017 Apr 18. PMID: 28420704.
      View in: PubMed
    2. Ikezaki H, Ai M, Schaefer EJ, Otokozawa S, Asztalos BF, Nakajima K, Zhou Y, Liu CT, Jacques PF, Cupples LA, Furusyo N. Cardiovascular disease prevalence and insulin resistance in the Kyushu-Okinawa Population Study and the Framingham Offspring Study. J Clin Lipidol. 2017 Mar - Apr; 11(2):348-356. PMID: 28502490.
      View in: PubMed
    3. Ikezaki H, Ai M, Schaefer EJ, Otokozawa S, Asztalos BF, Nakajima K, Zhou Y, Liu CT, Jacques PF, Cupples LA, Furusyo N. Ethnic Differences in Glucose Homeostasis Markers between the Kyushu-Okinawa Population Study and the Framingham Offspring Study. Sci Rep. 2016 Nov 10; 6:36725. PMID: 27830830.
      View in: PubMed
    4. Tsunoda F, Lamon-Fava S, Horvath KV, Schaefer EJ, Asztalos BF. Comparing fluorescence-based cell-free assays for the assessment of antioxidative capacity of high-density lipoproteins. Lipids Health Dis. 2016 Sep 22; 15(1):163. PMID: 27658709.
      View in: PubMed
    5. Asztalos IB, Gleason JA, Sever S, Gedik R, Asztalos BF, Horvath KV, Dansinger ML, Lamon-Fava S, Schaefer EJ. Effects of eicosapentaenoic acid and docosahexaenoic acid on cardiovascular disease risk factors: a randomized clinical trial. Metabolism. 2016 Nov; 65(11):1636-1645. PMID: 27733252.
      View in: PubMed
    6. Schaefer EJ, Anthanont P, Diffenderfer MR, Polisecki E, Asztalos BF. Diagnosis and treatment of high density lipoprotein deficiency. Prog Cardiovasc Dis. 2016 Sep - Oct; 59(2):97-106. PMID: 27565770.
      View in: PubMed
    7. Tani M, Horvath KV, Lamarche B, Couture P, Burnett JR, Schaefer EJ, Asztalos BF. High-density lipoprotein subpopulation profiles in lipoprotein lipase and hepatic lipase deficiency. Atherosclerosis. 2016 Oct; 253:7-14. PMID: 27573733.
      View in: PubMed
    8. Reyes-Soffer G, Millar JS, Ngai C, Jumes P, Coromilas E, Asztalos B, Johnson-Levonas AO, Wagner JA, Donovan DS, Karmally W, Ramakrishnan R, Holleran S, Thomas T, Dunbar RL, deGoma EM, Rafeek H, Baer AL, Liu Y, Lassman ME, Gutstein DE, Rader DJ, Ginsberg HN. Cholesteryl Ester Transfer Protein Inhibition With Anacetrapib Decreases Fractional Clearance Rates of High-Density Lipoprotein Apolipoprotein A-I and Plasma Cholesteryl Ester Transfer Protein. Arterioscler Thromb Vasc Biol. 2016 May; 36(5):994-1002. PMID: 26966279.
      View in: PubMed
    9. Kempen HJ, Asztalos BF, Moerland M, Jeyarajah E, Otvos J, Kallend DG, Bellibas SE, Wijngaard PL. High-Density Lipoprotein Subfractions and Cholesterol Efflux Capacities After Infusion of MDCO-216 (Apolipoprotein A-IMilano/Palmitoyl-Oleoyl-Phosphatidylcholine) in Healthy Volunteers and Stable Coronary Artery Disease Patients. Arterioscler Thromb Vasc Biol. 2016 Apr; 36(4):736-42. PMID: 26916733.
      View in: PubMed
    10. Tsunoda F, Asztalos IB, Horvath KV, Steiner G, Schaefer EJ, Asztalos BF. Fenofibrate, HDL, and cardiovascular disease in Type-2 diabetes: The DAIS trial. Atherosclerosis. 2016 Apr; 247:35-9. PMID: 26854974.
      View in: PubMed
    11. Pullinger CR, Stock EO, Movsesyan I, Malloy MJ, Frost PH, Tripuraneni R, Quinn AG, Ishida BY, Schaefer EJ, Asztalos BF, Kane JP. Identification and metabolic profiling of patients with lysosomal acid lipase deficiency. J Clin Lipidol. 2015 Sep-Oct; 9(5):716-726.e1. PMID: 26350820.
      View in: PubMed
    12. Chen CY, Holbrook M, Duess MA, Dohadwala MM, Hamburg NM, Asztalos BF, Milbury PE, Blumberg JB, Vita JA. Effect of almond consumption on vascular function in patients with coronary artery disease: a randomized, controlled, cross-over trial. Nutr J. 2015; 14(1):61. PMID: 26080804.
      View in: PubMed
    13. Tsunoda F, Lamon-Fava S, Asztalos BF, Iyer LK, Richardson K, Schaefer EJ. Effects of oral eicosapentaenoic acid versus docosahexaenoic acid on human peripheral blood mononuclear cell gene expression. Atherosclerosis. 2015 Aug; 241(2):400-8. PMID: 26074314.
      View in: PubMed
    14. Le NA, Diffenderfer MR, Thongtang N, Ooi EM, Barrett PH, Horvath KV, Dolnikowski GG, Asztalos BF, Schaefer EJ, Brown WV. Rosuvastatin Enhances the Catabolism of LDL apoB-100 in Subjects with Combined Hyperlipidemia in a Dose Dependent Manner. Lipids. 2015 May; 50(5):447-58. PMID: 25809021.
      View in: PubMed
    15. Anthanont P, Asztalos BF, Polisecki E, Zachariah B, Schaefer EJ. Case report: A novel apolipoprotein A-I missense mutation apoA-I (Arg149Ser)Boston associated with decreased lecithin-cholesterol acyltransferase activation and cellular cholesterol efflux. J Clin Lipidol. 2015 May-Jun; 9(3):390-5. PMID: 26073399.
      View in: PubMed
    16. Kempen HJ, Schranz DB, Asztalos BF, Otvos J, Jeyarajah E, Drazul-Schrader D, Collins HL, Adelman SJ, Wijngaard PL. Incubation of MDCO-216 (ApoA-IMilano/POPC) with Human Serum Potentiates ABCA1-Mediated Cholesterol Efflux Capacity, Generates New Prebeta-1 HDL, and Causes an Increase in HDL Size. J Lipids. 2014; 2014:923903. PMID: 25478232.
      View in: PubMed
    17. Asztalos BF, Horan MS, Horvath KV, McDermott AY, Chalasani NP, Schaefer EJ. Obesity associated molecular forms of C-reactive protein in human. PLoS One. 2014; 9(10):e109238. PMID: 25299074; PMCID: PMC4192316.
      View in: PubMed
      View in: PubMed Central
    18. Mak AC, Pullinger CR, Tang LF, Wong JS, Deo RC, Schwarz JM, Gugliucci A, Movsesyan I, Ishida BY, Chu C, Poon A, Kim P, Stock EO, Schaefer EJ, Asztalos BF, Castellano JM, Wyss-Coray T, Duncan JL, Miller BL, Kane JP, Kwok PY, Malloy MJ. Effects of the absence of apolipoprotein e on lipoproteins, neurocognitive function, and retinal function. JAMA Neurol. 2014 Oct; 71(10):1228-36. PMID: 25111166.
      View in: PubMed
    19. Russo GT, Giandalia A, Romeo EL, Alibrandi A, Horvath KV, Asztalos BF, Cucinotta D. Markers of Systemic Inflammation and Apo-AI Containing HDL Subpopulations in Women with and without Diabetes. Int J Endocrinol. 2014; 2014:607924. PMID: 25258627; PMCID: PMC4167212.
      View in: PubMed
      View in: PubMed Central
    20. Paranandi A, Asztalos BF, Mangili A, Kuvin J, Gerrior J, Sheehan H, Skinner SC, Tang AM, Wanke CA. Short communication: effects of omega-3 fatty acids on triglycerides and high-density lipoprotein subprofiles in HIV-infected persons with hypertriglyceridemia. AIDS Res Hum Retroviruses. 2014 Aug; 30(8):800-5. PMID: 24988179; PMCID: PMC4118719 [Available on 08/01/15].
      View in: PubMed
      View in: PubMed Central
    21. Asztalos BF, Matera R, Horvath KV, Horan M, Tani M, Polak JF, Skinner S, Wanke CA. Cardiovascular Disease-Risk Markers in HIV Patients. J AIDS Clin Res. 2014 Jun 12; 5(7). PMID: 26005590.
      View in: PubMed
    22. Anthanont P, Polisecki E, Asztalos BF, Diffenderfer MR, Barrett PH, Millar JS, Billheimer J, Cuchel M, Rader DJ, Schaefer EJ. A novel ApoA-I truncation (ApoA-IMytilene) associated with decreased ApoA-I production. Atherosclerosis. 2014 Aug; 235(2):470-6. PMID: 24950002.
      View in: PubMed
    23. Schaefer EJ, Anthanont P, Asztalos BF. High-density lipoprotein metabolism, composition, function, and deficiency. Curr Opin Lipidol. 2014 Jun; 25(3):194-9. PMID: 24785961.
      View in: PubMed
    24. Russo GT, Giandalia A, Romeo EL, Marotta M, Alibrandi A, De Francesco C, Horvath KV, Asztalos B, Cucinotta D. Lipid and non-lipid cardiovascular risk factors in postmenopausal type 2 diabetic women with and without coronary heart disease. J Endocrinol Invest. 2014 Mar; 37(3):261-8. PMID: 24615362.
      View in: PubMed
    25. Tani M, Matera R, Horvath KV, Hasan TS, Schaefer EJ, Asztalos BF. The influence of apoE-deficiency and LDL-receptor-deficiency on the HDL subpopulation profile in mice and in humans. Atherosclerosis. 2014 Mar; 233(1):39-44. PMID: 24529120.
      View in: PubMed
    26. Dimick SM, Sallee B, Asztalos BF, Pritchard PH, Frohlich J, Schaefer EJ. A kindred with fish eye disease, corneal opacities, marked high-density lipoprotein deficiency, and statin therapy. J Clin Lipidol. 2014 Mar-Apr; 8(2):223-30. PMID: 24636183.
      View in: PubMed
    27. Voros S, Joshi P, Qian Z, Rinehart S, Vazquez-Figueroa JG, Anderson H, Elashoff M, Murrieta L, Karmpaliotis D, Kalynych A, Brown C, Schaefer E, Asztalos B. Apoprotein B, small-dense LDL and impaired HDL remodeling is associated with larger plaque burden and more noncalcified plaque as assessed by coronary CT angiography and intravascular ultrasound with radiofrequency backscatter: results from the ATLANTA I study. J Am Heart Assoc. 2013; 2(6):e000344. PMID: 24252842; PMCID: PMC3886774.
      View in: PubMed
      View in: PubMed Central
    28. Niesor EJ, Gauthamadasa K, Silva RA, Suchankova G, Kallend D, Gylling H, Asztalos B, Damonte E, Rossomanno S, Abt M, Davidson WS, Benghozi R. Xanthophylls, phytosterols and pre-ß1-HDL are differentially affected by fenofibrate and niacin HDL-raising in a cross-over study. Lipids. 2013 Dec; 48(12):1185-96. PMID: 24068631.
      View in: PubMed
    29. Joshi PH, Rinehart S, Vazquez G, Qian Z, Sharma A, Anderson H, Murrieta L, Flockhart N, Karmpaliotis D, Kalynych A, Asztalos B, Elashoff MR, Blanchard J, Rosenberg S, Brown C, Voros S. A peripheral blood gene expression score is associated with plaque volume and phenotype by intravascular ultrasound with radiofrequency backscatter analysis: results from the ATLANTA study. Cardiovasc Diagn Ther. 2013 Mar; 3(1):5-14. PMID: 24282740; PMCID: PMC3839219.
      View in: PubMed
      View in: PubMed Central
    30. Singaraja RR, Sivapalaratnam S, Hovingh K, Dubé MP, Castro-Perez J, Collins HL, Adelman SJ, Riwanto M, Manz J, Hubbard B, Tietjen I, Wong K, Mitnaul LJ, van Heek M, Lin L, Roddy TA, McEwen J, Dallinge-Thie G, van Vark-van der Zee L, Verwoert G, Winther M, van Duijn C, Hofman A, Trip MD, Marais AD, Asztalos B, Landmesser U, Sijbrands E, Kastelein JJ, Hayden MR. The impact of partial and complete loss-of-function mutations in endothelial lipase on high-density lipoprotein levels and functionality in humans. Circ Cardiovasc Genet. 2013 Feb; 6(1):54-62. PMID: 23243195.
      View in: PubMed
    31. Thongtang N, Diffenderfer MR, Ooi EM, Asztalos BF, Dolnikowski GG, Lamon-Fava S, Schaefer EJ. Effects of atorvastatin on human C-reactive protein metabolism. Atherosclerosis. 2013 Feb; 226(2):466-70. PMID: 23218801.
      View in: PubMed
    32. Lee EY, Klementowicz PT, Hegele RA, Asztalos BF, Schaefer EJ. HDL deficiency due to a new insertion mutation (ApoA-INashua) and review of the literature. J Clin Lipidol. 2013 Mar-Apr; 7(2):169-73. PMID: 23415437.
      View in: PubMed
    33. Negi SI, Brautbar A, Virani SS, Anand A, Polisecki E, Asztalos BF, Ballantyne CM, Schaefer EJ, Jones PH. A novel mutation in the ABCA1 gene causing an atypical phenotype of Tangier disease. J Clin Lipidol. 2013 Jan-Feb; 7(1):82-7. PMID: 23351586.
      View in: PubMed
    34. Thongtang N, Diffenderfer MR, Ooi EM, Asztalos BF, Dolnikowski GG, Lamon-Fava S, Schaefer EJ. Linkage between C-reactive protein and triglyceride-rich lipoprotein metabolism. Metabolism. 2013 Mar; 62(3):369-75. PMID: 23018145.
      View in: PubMed
    35. de la Llera Moya M, McGillicuddy FC, Hinkle CC, Byrne M, Joshi MR, Nguyen V, Tabita-Martinez J, Wolfe ML, Badellino K, Pruscino L, Mehta NN, Asztalos BF, Reilly MP. Inflammation modulates human HDL composition and function in vivo. Atherosclerosis. 2012 Jun; 222(2):390-4. PMID: 22456230; NIHMSID: NIHMS367453.
      View in: PubMed
    36. Sankaranarayanan S, Kellner-Weibel G, de la Llera-Moya M, Phillips MC, Asztalos BF, Bittman R, Rothblat GH. A sensitive assay for ABCA1-mediated cholesterol efflux using BODIPY-cholesterol. J Lipid Res. 2011 Dec; 52(12):2332-40. PMID: 21957199; PMCID: PMC3220299.
      View in: PubMed
      View in: PubMed Central
    37. Sorci-Thomas MG, Zabalawi M, Bharadwaj MS, Wilhelm AJ, Owen JS, Asztalos BF, Bhat S, Thomas MJ. Dysfunctional HDL containing L159R ApoA-I leads to exacerbation of atherosclerosis in hyperlipidemic mice. Biochim Biophys Acta. 2012 Mar; 1821(3):502-12. PMID: 21944998; NIHMSID: NIHMS473495.
      View in: PubMed
    38. Roshan B, Ganda OP, Desilva R, Ganim RB, Ward E, Haessler SD, Polisecki EY, Asztalos BF, Schaefer EJ. Homozygous lecithin:cholesterol acyltransferase (LCAT) deficiency due to a new loss of function mutation and review of the literature. J Clin Lipidol. 2011 Nov-Dec; 5(6):493-9. PMID: 22108153.
      View in: PubMed
    39. Ai M, Otokozawa S, Asztalos BF, White CC, Cupples LA, Nakajima K, Lamon-Fava S, Wilson PW, Matsuzawa Y, Schaefer EJ. Adiponectin: an independent risk factor for coronary heart disease in men in the Framingham offspring Study. Atherosclerosis. 2011 Aug; 217(2):543-8. PMID: 21741045; NIHMSID: NIHMS351960.
      View in: PubMed
    40. Asztalos BF, Tani M, Schaefer EJ. Metabolic and functional relevance of HDL subspecies. Curr Opin Lipidol. 2011 Jun; 22(3):176-85. PMID: 21537175.
      View in: PubMed
    41. Sun JK, Keenan HA, Cavallerano JD, Asztalos BF, Schaefer EJ, Sell DR, Strauch CM, Monnier VM, Doria A, Aiello LP, King GL. Protection from retinopathy and other complications in patients with type 1 diabetes of extreme duration: the joslin 50-year medalist study. Diabetes Care. 2011 Apr; 34(4):968-74. PMID: 21447665; PMCID: PMC3064059.
      View in: PubMed
      View in: PubMed Central
    42. Thongtang N, Ai M, Otokozawa S, Himbergen TV, Asztalos BF, Nakajima K, Stein E, Jones PH, Schaefer EJ. Effects of maximal atorvastatin and rosuvastatin treatment on markers of glucose homeostasis and inflammation. Am J Cardiol. 2011 Feb 1; 107(3):387-92. PMID: 21257003.
      View in: PubMed
    43. Asztalos BF. High-density lipoprotein particles, coronary heart disease, and niacin. J Clin Lipidol. 2010 Sep-Oct; 4(5):405-10. PMID: 21122684.
      View in: PubMed
    44. Sankaranarayanan S, de la Llera-Moya M, Drazul-Schrader D, Asztalos BF, Weibel GL, Rothblat GH. Importance of macrophage cholesterol content on the flux of cholesterol mass. J Lipid Res. 2010 Nov; 51(11):3243-9. PMID: 20713652; PMCID: PMC2952564.
      View in: PubMed
      View in: PubMed Central
    45. Asztalos BF, Mujawar Z, Morrow MP, Grant A, Pushkarsky T, Wanke C, Shannon R, Geyer M, Kirchhoff F, Sviridov D, Fitzgerald ML, Bukrinsky M, Mansfield KG. Circulating Nef induces dyslipidemia in simian immunodeficiency virus-infected macaques by suppressing cholesterol efflux. J Infect Dis. 2010 Aug 15; 202(4):614-23. PMID: 20617930; NIHMSID: NIHMS203840.
      View in: PubMed
    46. Schaefer EJ, Santos RD, Asztalos BF. Marked HDL deficiency and premature coronary heart disease. Curr Opin Lipidol. 2010 Aug; 21(4):289-97. PMID: 20616715.
      View in: PubMed
    47. Asztalos BF, Swarbrick MM, Schaefer EJ, Dallal GE, Horvath KV, Ai M, Stanhope KL, Austrheim-Smith I, Wolfe BM, Ali M, Havel PJ. Effects of weight loss, induced by gastric bypass surgery, on HDL remodeling in obese women. J Lipid Res. 2010 Aug; 51(8):2405-12. PMID: 20631298; PMCID: PMC2903819.
      View in: PubMed
      View in: PubMed Central
    48. Lamon-Fava S, Herrington DM, Horvath KV, Schaefer EJ, Asztalos BF. Effect of hormone replacement therapy on plasma lipoprotein levels and coronary atherosclerosis progression in postmenopausal women according to type 2 diabetes mellitus status. Metabolism. 2010 Dec; 59(12):1794-800. PMID: 20580029; NIHMSID: NIHMS209706.
      View in: PubMed
    49. Ai M, Otokozawa S, Asztalos BF, Ito Y, Nakajima K, White CC, Cupples LA, Wilson PW, Schaefer EJ. Small dense LDL cholesterol and coronary heart disease: results from the Framingham Offspring Study. Clin Chem. 2010 Jun; 56(6):967-76. PMID: 20431054; NIHMSID: NIHMS476458.
      View in: PubMed
    50. Otokozawa S, Ai M, Asztalos BF, White CC, Demissie-Banjaw S, Cupples LA, Nakajima K, Wilson PW, Schaefer EJ. Direct assessment of plasma low density lipoprotein and high density lipoprotein cholesterol levels and coronary heart disease: results from the Framingham Offspring Study. Atherosclerosis. 2010 Nov; 213(1):251-5. PMID: 20863498; NIHMSID: NIHMS472524.
      View in: PubMed
    51. Chaychi L, Kinlaw WB, Asztalos BF, Schaefer EJ. A case report of a diabetic woman with very low HDL cholesterol. J Clin Lipidol. 2010 Mar-Apr; 4(2):133-5. PMID: 21122641.
      View in: PubMed
    52. de la Llera-Moya M, Drazul-Schrader D, Asztalos BF, Cuchel M, Rader DJ, Rothblat GH. The ability to promote efflux via ABCA1 determines the capacity of serum specimens with similar high-density lipoprotein cholesterol to remove cholesterol from macrophages. Arterioscler Thromb Vasc Biol. 2010 Apr; 30(4):796-801. PMID: 20075420; NIHMSID: NIHMS181032.
      View in: PubMed
    53. Russo GT, Horvath KV, Di Benedetto A, Giandalia A, Cucinotta D, Asztalos B. Influence of menopause and cholesteryl ester transfer protein (CETP) TaqIB polymorphism on lipid profile and HDL subpopulations distribution in women with and without type 2 diabetes. Atherosclerosis. 2010 May; 210(1):294-301. PMID: 20006332.
      View in: PubMed
    54. Otokozawa S, Ai M, Diffenderfer MR, Asztalos BF, Tanaka A, Lamon-Fava S, Schaefer EJ. Fasting and postprandial apolipoprotein B-48 levels in healthy, obese, and hyperlipidemic subjects. Metabolism. 2009 Nov; 58(11):1536-42. PMID: 19592048.
      View in: PubMed
    55. Lamon-Fava S, Asztalos BF, Howard TD, Reboussin DM, Horvath KV, Schaefer EJ, Herrington DM. Association of polymorphisms in genes involved in lipoprotein metabolism with plasma concentrations of remnant lipoproteins and HDL subpopulations before and after hormone therapy in postmenopausal women. Clin Endocrinol (Oxf). 2010 Feb; 72(2):169-75. PMID: 19489872; NIHMSID: NIHMS139981.
      View in: PubMed
    56. Ai M, Otokozawa S, Schaefer EJ, Asztalos BF, Nakajima K, Shrader P, Kathiresan S, Meigs JB, Williams G, Nathan DM. Glycated albumin and direct low density lipoprotein cholesterol levels in type 2 diabetes mellitus. Clin Chim Acta. 2009 Aug; 406(1-2):71-4. PMID: 19465013; NIHMSID: NIHMS490105.
      View in: PubMed
    57. Wada M, Iso T, Asztalos BF, Takama N, Nakajima T, Seta Y, Kaneko K, Taniguchi Y, Kobayashi H, Nakajima K, Schaefer EJ, Kurabayashi M. Marked high density lipoprotein deficiency due to apolipoprotein A-I Tomioka (codon 138 deletion). Atherosclerosis. 2009 Nov; 207(1):157-61. PMID: 19473658.
      View in: PubMed
    58. Brousseau ME, Millar JS, Diffenderfer MR, Nartsupha C, Asztalos BF, Wolfe ML, Mancuso JP, Digenio AG, Rader DJ, Schaefer EJ. Effects of cholesteryl ester transfer protein inhibition on apolipoprotein A-II-containing HDL subspecies and apolipoprotein A-II metabolism. J Lipid Res. 2009 Jul; 50(7):1456-62. PMID: 19193611; PMCID: PMC2694343.
      View in: PubMed
      View in: PubMed Central
    59. West M, Greason E, Kolmakova A, Jahangiri A, Asztalos B, Pollin TI, Rodriguez A. Scavenger receptor class B type I protein as an independent predictor of high-density lipoprotein cholesterol levels in subjects with hyperalphalipoproteinemia. J Clin Endocrinol Metab. 2009 Apr; 94(4):1451-7. PMID: 19158204; PMCID: PMC2682469.
      View in: PubMed
      View in: PubMed Central
    60. Sacks FM, Rudel LL, Conner A, Akeefe H, Kostner G, Baki T, Rothblat G, de la Llera-Moya M, Asztalos B, Perlman T, Zheng C, Alaupovic P, Maltais JA, Brewer HB. Selective delipidation of plasma HDL enhances reverse cholesterol transport in vivo. J Lipid Res. 2009 May; 50(5):894-907. PMID: 19144994; PMCID: PMC2666176.
      View in: PubMed
      View in: PubMed Central
    61. Lamon-Fava S, Herrington DM, Reboussin DM, Sherman M, Horvath K, Schaefer EJ, Asztalos BF. Changes in remnant and high-density lipoproteins associated with hormone therapy and progression of coronary artery disease in postmenopausal women. Atherosclerosis. 2009 Jul; 205(1):325-30. PMID: 19155011; NIHMSID: NIHMS83593.
      View in: PubMed
    62. Otokozawa S, Ai M, Van Himbergen T, Asztalos BF, Tanaka A, Stein EA, Jones PH, Schaefer EJ. Effects of intensive atorvastatin and rosuvastatin treatment on apolipoprotein B-48 and remnant lipoprotein cholesterol levels. Atherosclerosis. 2009 Jul; 205(1):197-201. PMID: 19200542.
      View in: PubMed
    63. Sankaranarayanan S, Oram JF, Asztalos BF, Vaughan AM, Lund-Katz S, Adorni MP, Phillips MC, Rothblat GH. Effects of acceptor composition and mechanism of ABCG1-mediated cellular free cholesterol efflux. J Lipid Res. 2009 Feb; 50(2):275-84. PMID: 18827283; PMCID: PMC2636919.
      View in: PubMed
      View in: PubMed Central
    64. Lamon-Fava S, Diffenderfer MR, Barrett PH, Buchsbaum A, Nyaku M, Horvath KV, Asztalos BF, Otokozawa S, Ai M, Matthan NR, Lichtenstein AH, Dolnikowski GG, Schaefer EJ. Extended-release niacin alters the metabolism of plasma apolipoprotein (Apo) A-I and ApoB-containing lipoproteins. Arterioscler Thromb Vasc Biol. 2008 Sep; 28(9):1672-8. PMID: 18566298; NIHMSID: NIHMS125995.
      View in: PubMed
    65. Santos RD, Asztalos BF, Martinez LR, Miname MH, Polisecki E, Schaefer EJ. Clinical presentation, laboratory values, and coronary heart disease risk in marked high-density lipoprotein-deficiency states. J Clin Lipidol. 2008 Aug; 2(4):237-47. PMID: 21291740.
      View in: PubMed
    66. Russo GT, Di Benedetto A, Alessi E, Giandalia A, Gaudio A, Ientile R, Horvath KV, Asztalos B, Raimondo G, Cucinotta D. Menopause modulates homocysteine levels in diabetic and non-diabetic women. J Endocrinol Invest. 2008 Jun; 31(6):546-51. PMID: 18591889.
      View in: PubMed
    67. Robins SJ, Collins D, Nelson JJ, Bloomfield HE, Asztalos BF. Cardiovascular events with increased lipoprotein-associated phospholipase A(2) and low high-density lipoprotein-cholesterol: the Veterans Affairs HDL Intervention Trial. Arterioscler Thromb Vasc Biol. 2008 Jun; 28(6):1172-8. PMID: 18356553.
      View in: PubMed
    68. Lamon-Fava S, Herrington DM, Reboussin DM, Sherman M, Horvath KV, Cupples LA, White C, Demissie S, Schaefer EJ, Asztalos BF. Plasma levels of HDL subpopulations and remnant lipoproteins predict the extent of angiographically-defined coronary artery disease in postmenopausal women. Arterioscler Thromb Vasc Biol. 2008 Mar; 28(3):575-9. PMID: 18174456.
      View in: PubMed
    69. Asztalos BF, Collins D, Horvath KV, Bloomfield HE, Robins SJ, Schaefer EJ. Relation of gemfibrozil treatment and high-density lipoprotein subpopulation profile with cardiovascular events in the Veterans Affairs High-Density Lipoprotein Intervention Trial. Metabolism. 2008 Jan; 57(1):77-83. PMID: 18078862; NIHMSID: NIHMS36505.
      View in: PubMed
    70. Ai M, Otokozawa S, Asztalos BF, Nakajima K, Stein E, Jones PH, Schaefer EJ. Effects of maximal doses of atorvastatin versus rosuvastatin on small dense low-density lipoprotein cholesterol levels. Am J Cardiol. 2008 Feb 1; 101(3):315-8. PMID: 18237592.
      View in: PubMed
    71. Schaefer EJ, Asztalos BF. Increasing high-density lipoprotein cholesterol, inhibition of cholesteryl ester transfer protein, and heart disease risk reduction. Am J Cardiol. 2007 Dec 3; 100(11 A):n25-31. PMID: 18047849.
      View in: PubMed
    72. Santos RD, Schaefer EJ, Asztalos BF, Polisecki E, Wang J, Hegele RA, Martinez LR, Miname MH, Rochitte CE, Da Luz PL, Maranhão RC. Characterization of high density lipoprotein particles in familial apolipoprotein A-I deficiency. J Lipid Res. 2008 Feb; 49(2):349-57. PMID: 17991756.
      View in: PubMed
    73. Schaefer EJ, Asztalos BF. Where are we with high-density lipoprotein raising and inhibition of cholesteryl ester transfer for heart disease risk reduction? Curr Opin Cardiol. 2007 Jul; 22(4):373-8. PMID: 17556892.
      View in: PubMed
    74. Lamon-Fava S, Diffenderfer MR, Barrett PH, Buchsbaum A, Matthan NR, Lichtenstein AH, Dolnikowski GG, Horvath K, Asztalos BF, Zago V, Schaefer EJ. Effects of different doses of atorvastatin on human apolipoprotein B-100, B-48, and A-I metabolism. J Lipid Res. 2007 Aug; 48(8):1746-53. PMID: 17526934.
      View in: PubMed
    75. Asztalos BF, Le Maulf F, Dallal GE, Stein E, Jones PH, Horvath KV, McTaggart F, Schaefer EJ. Comparison of the effects of high doses of rosuvastatin versus atorvastatin on the subpopulations of high-density lipoproteins. Am J Cardiol. 2007 Mar 1; 99(5):681-5. PMID: 17317371.
      View in: PubMed
    76. Asztalos BF, Schaefer EJ, Horvath KV, Yamashita S, Miller M, Franceschini G, Calabresi L. Role of LCAT in HDL remodeling: investigation of LCAT deficiency states. J Lipid Res. 2007 Mar; 48(3):592-9. PMID: 17183024.
      View in: PubMed
    77. Boadu E, Choi HY, Lee DW, Waddington EI, Chan T, Asztalos B, Vance JE, Chan A, Castro G, Francis GA. Correction of apolipoprotein A-I-mediated lipid efflux and high density lipoprotein particle formation in human Niemann-Pick type C disease fibroblasts. J Biol Chem. 2006 Dec 1; 281(48):37081-90. PMID: 17020879.
      View in: PubMed
    78. Schaefer EJ, Asztalos BF. Cholesteryl ester transfer protein inhibition, high-density lipoprotein metabolism and heart disease risk reduction. Curr Opin Lipidol. 2006 Aug; 17(4):394-8. PMID: 16832162.
      View in: PubMed
    79. Schaefer EJ, Asztalos BF. Should we target HDL-cholesterol to reduce coronary heart disease risk? Nat Clin Pract Endocrinol Metab. 2006 Jul; 2(7):358-9. PMID: 16932315.
      View in: PubMed
    80. Schaefer EJ, Asztalos BF. The effects of statins on high-density lipoproteins. Curr Atheroscler Rep. 2006 Jan; 8(1):41-9. PMID: 16455013.
      View in: PubMed
    81. Asztalos BF, Demissie S, Cupples LA, Collins D, Cox CE, Horvath KV, Bloomfield HE, Robins SJ, Schaefer EJ. LpA-I, LpA-I:A-II HDL and CHD-risk: The Framingham Offspring Study and the Veterans Affairs HDL Intervention Trial. Atherosclerosis. 2006 Sep; 188(1):59-67. PMID: 16298372.
      View in: PubMed
    82. Asztalos BF, Collins D, Cupples LA, Demissie S, Horvath KV, Bloomfield HE, Robins SJ, Schaefer EJ. Value of high-density lipoprotein (HDL) subpopulations in predicting recurrent cardiovascular events in the Veterans Affairs HDL Intervention Trial. Arterioscler Thromb Vasc Biol. 2005 Oct; 25(10):2185-91. PMID: 16123324.
      View in: PubMed
    83. Asztalos BF, de la Llera-Moya M, Dallal GE, Horvath KV, Schaefer EJ, Rothblat GH. Differential effects of HDL subpopulations on cellular ABCA1- and SR-BI-mediated cholesterol efflux. J Lipid Res. 2005 Oct; 46(10):2246-53. PMID: 16061948.
      View in: PubMed
    84. Asztalos BF, Schaefer EJ, Horvath KV, Cox CE, Skinner S, Gerrior J, Gorbach SL, Wanke C. Protease inhibitor-based HAART, HDL, and CHD-risk in HIV-infected patients. Atherosclerosis. 2006 Jan; 184(1):72-7. PMID: 15935358.
      View in: PubMed
    85. Schaefer EJ, McNamara JR, Asztalos BF, Tayler T, Daly JA, Gleason JL, Seman LJ, Ferrari A, Rubenstein JJ. Effects of atorvastatin versus other statins on fasting and postprandial C-reactive protein and lipoprotein-associated phospholipase A2 in patients with coronary heart disease versus control subjects. Am J Cardiol. 2005 May 1; 95(9):1025-32. PMID: 15842965.
      View in: PubMed
    86. Brousseau ME, Diffenderfer MR, Millar JS, Nartsupha C, Asztalos BF, Welty FK, Wolfe ML, Rudling M, Björkhem I, Angelin B, Mancuso JP, Digenio AG, Rader DJ, Schaefer EJ. Effects of cholesteryl ester transfer protein inhibition on high-density lipoprotein subspecies, apolipoprotein A-I metabolism, and fecal sterol excretion. Arterioscler Thromb Vasc Biol. 2005 May; 25(5):1057-64. PMID: 15761191; NIHMSID: NIHMS332629.
      View in: PubMed
    87. Batista MC, Welty FK, Diffenderfer MR, Sarnak MJ, Schaefer EJ, Lamon-Fava S, Asztalos BF, Dolnikowski GG, Brousseau ME, Marsh JB. Apolipoprotein A-I, B-100, and B-48 metabolism in subjects with chronic kidney disease, obesity, and the metabolic syndrome. Metabolism. 2004 Oct; 53(10):1255-61. PMID: 15375779.
      View in: PubMed
    88. Asztalos BF, Cupples LA, Demissie S, Horvath KV, Cox CE, Batista MC, Schaefer EJ. High-density lipoprotein subpopulation profile and coronary heart disease prevalence in male participants of the Framingham Offspring Study. Arterioscler Thromb Vasc Biol. 2004 Nov; 24(11):2181-7. PMID: 15388521.
      View in: PubMed
    89. Asztalos BF. High-density lipoprotein metabolism and progression of atherosclerosis: new insights from the HDL Atherosclerosis Treatment Study. Curr Opin Cardiol. 2004 Jul; 19(4):385-91. PMID: 15218401.
      View in: PubMed
    90. Webb NR, de Beer MC, Asztalos BF, Whitaker N, van der Westhuyzen DR, de Beer FC. Remodeling of HDL remnants generated by scavenger receptor class B type I. J Lipid Res. 2004 Sep; 45(9):1666-73. PMID: 15210842.
      View in: PubMed
    91. Yancey PG, Asztalos BF, Stettler N, Piccoli D, Williams DL, Connelly MA, Rothblat GH. SR-BI- and ABCA1-mediated cholesterol efflux to serum from patients with Alagille syndrome. J Lipid Res. 2004 Sep; 45(9):1724-32. PMID: 15210845.
      View in: PubMed
    92. Asztalos BF, Horvath KV, Kajinami K, Nartsupha C, Cox CE, Batista M, Schaefer EJ, Inazu A, Mabuchi H. Apolipoprotein composition of HDL in cholesteryl ester transfer protein deficiency. J Lipid Res. 2004 Mar; 45(3):448-55. PMID: 14657195.
      View in: PubMed
    93. Lamon-Fava S, Posfai B, Asztalos BF, Horvath KV, Dallal GE, Schaefer EJ. Effects of estrogen and medroxyprogesterone acetate on subpopulations of triglyceride-rich lipoproteins and high-density lipoproteins. Metabolism. 2003 Oct; 52(10):1330-6. PMID: 14564686.
      View in: PubMed
    94. Asztalos BF, Schaefer EJ. High-density lipoprotein subpopulations in pathologic conditions. Am J Cardiol. 2003 Apr 3; 91(7A):12E-17E. PMID: 12679198.
      View in: PubMed
    95. Asztalos BF, Batista M, Horvath KV, Cox CE, Dallal GE, Morse JS, Brown GB, Schaefer EJ. Change in alpha1 HDL concentration predicts progression in coronary artery stenosis. Arterioscler Thromb Vasc Biol. 2003 May 1; 23(5):847-52. PMID: 12637338.
      View in: PubMed
    96. Asztalos BF, Schaefer EJ. HDL in atherosclerosis: actor or bystander? Atheroscler Suppl. 2003 Mar; 4(1):21-9. PMID: 12714034.
      View in: PubMed
    97. Asztalos BF, Horvath KV, McNamara JR, Roheim PS, Rubinstein JJ, Schaefer EJ. Effects of atorvastatin on the HDL subpopulation profile of coronary heart disease patients. J Lipid Res. 2002 Oct; 43(10):1701-7. PMID: 12364554.
      View in: PubMed
    98. Asztalos BF, Horvath KV, McNamara JR, Roheim PS, Rubinstein JJ, Schaefer EJ. Comparing the effects of five different statins on the HDL subpopulation profiles of coronary heart disease patients. Atherosclerosis. 2002 Oct; 164(2):361-9. PMID: 12204809.
      View in: PubMed
    99. Foster TA, Asztalos BF. Improved allocation of costs through analysis of variation in data: planning of laboratory studies. Clin Chim Acta. 2001 Dec; 314(1-2):55-66. PMID: 11718679.
      View in: PubMed
    100. Asztalos BF, Brousseau ME, McNamara JR, Horvath KV, Roheim PS, Schaefer EJ. Subpopulations of high density lipoproteins in homozygous and heterozygous Tangier disease. Atherosclerosis. 2001 May; 156(1):217-25. PMID: 11369017.
      View in: PubMed
    101. Asztalos BF, Roheim PS, Milani RL, Lefevre M, McNamara JR, Horvath KV, Schaefer EJ. Distribution of ApoA-I-containing HDL subpopulations in patients with coronary heart disease. Arterioscler Thromb Vasc Biol. 2000 Dec; 20(12):2670-6. PMID: 11116070.
      View in: PubMed
    102. Brousseau ME, Eberhart GP, Dupuis J, Asztalos BF, Goldkamp AL, Schaefer EJ, Freeman MW. Cellular cholesterol efflux in heterozygotes for tangier disease is markedly reduced and correlates with high density lipoprotein cholesterol concentration and particle size. J Lipid Res. 2000 Jul; 41(7):1125-35. PMID: 10884295.
      View in: PubMed
    103. Asztalos B, Lefevre M, Wong L, Foster TA, Tulley R, Windhauser M, Zhang W, Roheim PS. Differential response to low-fat diet between low and normal HDL-cholesterol subjects. J Lipid Res. 2000 Mar; 41(3):321-8. PMID: 10706579.
      View in: PubMed
    104. Asztalos B, Yamane T, Nishida M. Flow visualization analysis for evaluation of shear and recirculation in a new closed-type, monopivot centrifugal blood pump. Artif Organs. 1999 Oct; 23(10):939-46. PMID: 10564293.
      View in: PubMed
    105. Nishida M, Asztalos B, Yamane T, Masuzawa T, Tsukiya T, Endo S, Taenaka Y, Miyazoe Y, Ito K, Konishi Y. Flow visualization study to improve hemocompatibility of a centrifugal blood pump. Artif Organs. 1999 Aug; 23(8):697-703. PMID: 10463491.
      View in: PubMed
    106. Masuzawa T, Tsukiya T, Endo S, Tatsumi E, Taenaka Y, Takano H, Yamane T, Nishida M, Asztalos B, Miyazoe Y, Ito K, Sawairi T, Konishi Y. Development of design methods for a centrifugal blood pump with a fluid dynamic approach: results in hemolysis tests. Artif Organs. 1999 Aug; 23(8):757-61. PMID: 10463503.
      View in: PubMed
    107. Miyazoe Y, Sawairi T, Ito K, Konishi Y, Yamane T, Nishida M, Asztalos B, Masuzawa T, Tsukiya T, Endo S, Taenaka Y. Computational fluid dynamics analysis to establish the design process of a centrifugal blood pump: second report. Artif Organs. 1999 Aug; 23(8):762-8. PMID: 10463504.
      View in: PubMed
    108. Zhang W, Asztalos B, Roheim PS, Wong L. Characterization of phospholipids in pre-alpha HDL: selective phospholipid efflux with apolipoprotein A-I. J Lipid Res. 1998 Aug; 39(8):1601-7. PMID: 9717720.
      View in: PubMed
    109. Nishida M, Yamane T, Asztalos B. Washout hole flow measurement for the development of a centrifugal blood pump. Artif Organs. 1998 May; 22(5):386-92. PMID: 9609346.
      View in: PubMed
    110. Yamane T, Asztalos B, Nishida M, Masuzawa T, Takiura K, Taenaka Y, Konishi Y, Miyazoe Y, Ito K. Flow visualization as a complementary tool to hemolysis testing in the development of centrifugal blood pumps. Artif Organs. 1998 May; 22(5):375-80. PMID: 9609344.
      View in: PubMed
    111. Takiura K, Masuzawa T, Endo S, Wakisaka Y, Tatsumi E, Taenaka Y, Takano H, Yamane T, Nishida M, Asztalos B, Konishi Y, Miyazoe Y, Ito K. Development of design methods of a centrifugal blood pump with in vitro tests, flow visualization, and computational fluid dynamics: results in hemolysis tests. Artif Organs. 1998 May; 22(5):393-8. PMID: 9609347.
      View in: PubMed
    112. Asztalos BF, Lefevre M, Foster TA, Tulley R, Windhauser M, Wong L, Roheim PS. Normolipidemic subjects with low HDL cholesterol levels have altered HDL subpopulations. Arterioscler Thromb Vasc Biol. 1997 Oct; 17(10):1885-93. PMID: 9351350.
      View in: PubMed
    113. Yamane T, Nishida M, Asztalos B, Tsutsui T, Jikuya T. Fluid dynamic characteristics of monopivot magnetic suspension blood pumps. ASAIO J. 1997 Sep-Oct; 43(5):M635-8. PMID: 9360122.
      View in: PubMed
    114. Asztalos B, Zhang W, Roheim PS, Wong L. Role of free apolipoprotein A-I in cholesterol efflux. Formation of pre-alpha-migrating high-density lipoprotein particles. Arterioscler Thromb Vasc Biol. 1997 Sep; 17(9):1630-6. PMID: 9327755.
      View in: PubMed
    115. Nishida M, Yamane T, Orita T, Asztalos B, Clarke H. Quantitative visualization of flow through a centrifugal blood pump: effect of washout holes. Artif Organs. 1997 Jul; 21(7):720-9. PMID: 9212946.
      View in: PubMed
    116. Wong L, Sivok B, Kurucz E, Sloop CH, Roheim PS, Asztalos B. Lipid composition of HDL subfractions in dog plasma and lymph. Arterioscler Thromb Vasc Biol. 1995 Nov; 15(11):1875-81. PMID: 7583567.
      View in: PubMed
    117. Asztalos BF, Roheim PS. Presence and formation of 'free apolipoprotein A-I-like' particles in human plasma. Arterioscler Thromb Vasc Biol. 1995 Sep; 15(9):1419-23. PMID: 7670957.
      View in: PubMed
    118. de Beer MC, Yuan T, Kindy MS, Asztalos BF, Roheim PS, de Beer FC. Characterization of constitutive human serum amyloid A protein (SAA4) as an apolipoprotein. J Lipid Res. 1995 Mar; 36(3):526-34. PMID: 7775864.
      View in: PubMed
    119. Roheim PS, Asztalos BF. Clinical significance of lipoprotein size and risk for coronary atherosclerosis. Clin Chem. 1995 Jan; 41(1):147-52. PMID: 7813070.
      View in: PubMed
    120. Asztalos BF, Sloop CH, Wong L, Roheim PS. Comparison of apo A-I-containing subpopulations of dog plasma and prenodal peripheral lymph: evidence for alteration in subpopulations in the interstitial space. Biochim Biophys Acta. 1993 Sep 8; 1169(3):301-4. PMID: 7548124.
      View in: PubMed
    121. Asztalos BF, Sloop CH, Wong L, Roheim PS. Two-dimensional electrophoresis of plasma lipoproteins: recognition of new apo A-I-containing subpopulations. Biochim Biophys Acta. 1993 Sep 8; 1169(3):291-300. PMID: 7548123.
      View in: PubMed
    122. Szabó A, Nemcsók J, Asztalos B, Rakonczay Z, Kása P, Hieu LH. The effect of pesticides on carp (Cyprinus carpio L). Acetylcholinesterase and its biochemical characterization. Ecotoxicol Environ Saf. 1992 Feb; 23(1):39-45. PMID: 1375147.
      View in: PubMed
    123. Asztalos B, Nemcsók J, Benedeczky I, Gabriel R, Szabó A, Refaie OJ. The effects of pesticides on some biochemical parameters of carp (Cyprinus carpio L.). Arch Environ Contam Toxicol. 1990 Mar-Apr; 19(2):275-82. PMID: 2322021.
      View in: PubMed
    124. Asztalos B, Nemcsók J, Benedeczky I, Gabriel R, Szabó A. Comparison of effects of paraquat and methidation on enzyme activity and tissue necrosis of carp, following exposure to the pesticides singly or in combination. Environ Pollut. 1988; 55(2):123-35. PMID: 15092508.
      View in: PubMed
    125. Nemcsók J, Orbán L, Asztalos B, Vig E. Accumulation of pesticides in the organs of carp, Cyprinus carpio L., at 4 degrees and 20 degrees C. Bull Environ Contam Toxicol. 1987 Sep; 39(3):370-8. PMID: 3663990.
      View in: PubMed
    126. Vig E, Orbán L, Nemcsók J, Asztalos B. [Physiopathologic data on the action of selected fungicides and herbicides in carp]. Arch Exp Veterinarmed. 1987 Jul; 41(4):491-505. PMID: 3675117.
      View in: PubMed
    127. Nemcsók J, Asztalos B, Víg E, Orbán L. The effect of an organophosphorus pesticide on the enzymes of carp (Cyprinus carpio L.). Acta Biol Hung. 1987; 38(1):77-85. PMID: 3448863.
      View in: PubMed
    128. Asztalos B. LDH enzymes as a tool on monitoring tissue necrosis in fishes caused by pesticides. Acta Biol Hung. 1986; 37(1):59-65. PMID: 3591163.
      View in: PubMed
    129. Bencsáth P, Szénási G, Asztalos B, Takács L. Time course of denervation diuresis and natriuresis in the anaesthetized rat. Acta Physiol Hung. 1985; 66(1):47-50. PMID: 4036643.
      View in: PubMed
    130. Asztalos B, Nemcsók J. Effect of pesticides on the LDH activity and isoenzyme pattern of carp (Cyprinus carpio L.) sera. Comp Biochem Physiol C. 1985; 82(1):217-9. PMID: 2865066.
      View in: PubMed
    131. Bencsáth P, Asztalos B, Szalay L, Takács L. Renal handling of sodium after chronic renal sympathectomy in the anesthetized rat. Am J Physiol. 1979 Jun; 236(6):F513-8. PMID: 443433.
      View in: PubMed
    132. Asztalos B, Singely I, Varga T, Bodrogi L. [Our observation in the diagnosis of horseshoe kidney]. Orv Hetil. 1974 Oct 27; 115(43):2565-6. PMID: 4417180.
      View in: PubMed
    133. Ján H, Asztalos B, Géczy I. [Ovarian sarcoma in the 4th year of age]. Zentralbl Chir. 1972 Sep 30; 97(39):1400-1. PMID: 4638309.
      View in: PubMed
    134. Váry L, Karátson A, Bochkor B, Wabrosch G, Gyarmathy F, Bárd R, Pánykó E, Sallai Z, Pataky L, Asztalos B, Balogh F. [Clinical experiences on the carcinoma of the penis. Statistical analysis of a collected material]. Urol Int. 1971; 26(2):171-83. PMID: 5126014.
      View in: PubMed
    135. Ján H, Asztalos B, Simó G, Bujalka R. [Our cases of primary cancer of the choledochus]. Orv Hetil. 1970 Aug 9; 111(32):1885-7. PMID: 5470593.
      View in: PubMed
    136. Asztalos B, Ján H, Pirkner F. [Spontaneous necrosis of the large intestince]. Orv Hetil. 1968 Jul 21; 109(29):1609-11. PMID: 5710758.
      View in: PubMed
    137. Ján H, Asztalos B, Pirkner F. [Urachus anomalies in adults]. Zentralbl Chir. 1967 Jun 10; 92(23):819-23. PMID: 5590650.
      View in: PubMed
    138. Szekér K, Asztalos B. ["Cholelithiasis" caused by ascariasis]. Orv Hetil. 1967 Mar 12; 108(11):510-1. PMID: 6047077.
      View in: PubMed
    Asztalos's Networks
    Click the "See All" links for more information and interactive visualizations!
    Concepts Expand Description
    _
    Co-Authors Expand Description
    _
    Similar People Expand Description
    _
    Same Department Expand Description
    Physical Neighbors Expand Description
    _
    This website was supported by the National Center for Research Resources Award Number UL1RR025752 and the National Center for Advancing Translational Sciences, National Institutes of Health, Award Numbers UL1TR000073 and UL1TR001064. The content is solely the responsibility of the authors and does not necessarily represent the official views of the NIH.

    Disclaimer | Tufts University | Tufts CTSI 2015